Free Trial

Viatris: 1Q24 Results

HEALTHCARE

Viatris (VTRS: Baa3 stab / BBB- neg / BBB stab): 1Q24 Results


Revenue and EBITDA slightly below forecast at $3.66bn and $1.19bn respectively.

  • Total sales were down -2% on the year
  • Adj EBITDA -11% vs 1Q23
  • Free Cash Flow -39% on 1Q23

Emerging market growth was the bright spot in an otherwise uninspiring quarter. Scott A. Smith joined the board in Dec 22 and became the new CEO last month. The company is moving more into eye-care and divesting various underperforming businesses.

{https://event.choruscall.com/mediaframe/webcast.html?webcastid=VJx4XFxY}

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.